SCHEMBL17866069

SCHEMBL17866069

COC(=O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PYGB P11216 2/20 0.42
▸ PTGS1 P23219 2/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ PRKD3 O94806 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ PRKCB P05771 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ PRKCH P24723 1/20 0.40
▸ PRKCI P41743 1/20 0.40
▸ PRKCE Q02156 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ PRKCZ Q05513 1/20 0.40
▸ PRKCD Q05655 1/20 0.40
▸ PRKD1 Q15139 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ SLC2A1 P11166 1/20 0.38
▸ TLR4 O00206 1/20 0.38
▸ AMDHD2 Q9Y303 1/20 0.38
▸ LGALS3 P17931 1/20 0.36
▸ CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25167911 0.89 SLC2A1 (0.41) PYGBPTGS1PTGS2PRKD3PRKCG
SCHEMBL30514366 0.88 PYGB (0.53) PYGBPRKD3PRKCGPRKCBPRKCA
SCHEMBL17866085 0.85 PRKD3 (0.41) PYGBPTGS1PTGS2PRKD3PRKCG
SCHEMBL17866100 0.84 ALDH1A1 (0.45) PTGS1PTGS2PRKD3PRKCGPRKCB
SCHEMBL25887782 0.83 PRKD3 (0.43) PYGBPTGS1PTGS2PRKD3PRKCG
SCHEMBL12929985 0.82 FUCA1 (0.38) PYGBPRKD3PRKCGPRKCBPRKCA
SCHEMBL12899798 0.82 FUCA1 (0.38) PYGBPRKD3PRKCGPRKCBPRKCA
SCHEMBL9563973 0.81 PTGS1 (0.40) PYGBPTGS1PTGS2PRKD3PRKCG
SCHEMBL15963880 0.81 PTGS1 (0.40) PYGBPTGS1PTGS2PRKD3PRKCG
SCHEMBL8668910 0.81 PTGS1 (0.40) PYGBPTGS1PTGS2PRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1782828-B1 PROGRESSION INHIBITOR FOR DISEASE ATTRIBUTED TO ABNORMAL ACCUMULATION OF LIVER FAT KISSEI PHARMACEUTICAL (JP) 2016-06-29 — — EP claimed
Send feedback